BeiGene | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

Beigene Study ID

BGB-45035-101

ClinicalTrials.gov ID

NCT06342713

China Drug Trials ID

CTR20243170

Study Overview

Sex: All

Age: 18 Years / 75 Years

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years / 75 Years

No Study Documents